Pfizer Inc at Wells Fargo Healthcare Conference Transcript
Great. Thank you very much for joining us today in post-learn session. We'll keep it entertaining so that we don't -- yes. Thank you very much. And my name is Mohit Bansal. I'm one of the biopharma analysts here at Wells Fargo, and we have Pfizer management team today with us. We have Annaliesa Anderson, she's SVP and CSO, Vaccine R&D; and Rodrigo Puga, he's the U.S. Commercial and Global Business Lead of Internal Medicine; and we also have Chris Stevo, Head of IR at Pfizer. Thank you all for joining us today.
And Mohit, if I can just make -- briefly make a forward-looking statement and I'll let you all get to it. So I just wanted to inform you that we're going to be making forward-looking statements or may be making forward-looking statements today and anything we say is only valid as of today. And if you have any more questions on forward-looking statements, please see the relevant sections in our SEC
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
